Total Payments
$4,533
2024 Payments
$1,335
Companies
19
Transactions
198
Medicare Patients
17,690
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$4,419 (97.5%)
Education$113.84 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,419 | 193 | 97.5% |
| Education | $113.84 | 5 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $854.76 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $726.42 | 29 | $0 (2024) |
| Amgen Inc. | $686.25 | 33 | $0 (2024) |
| Travere Therapeutics, Inc. | $544.43 | 14 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $373.83 | 19 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $290.59 | 14 | $0 (2024) |
| Horizon Therapeutics plc | $227.45 | 11 | $0 (2023) |
| Vifor Pharma, Inc. | $147.96 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $140.64 | 7 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $121.07 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,335 | 55 | Travere Therapeutics, Inc. ($443.20) |
| 2023 | $1,209 | 58 | Amgen Inc. ($263.28) |
| 2022 | $1,280 | 51 | AstraZeneca Pharmaceuticals LP ($412.12) |
| 2021 | $673.67 | 32 | Bayer HealthCare Pharmaceuticals Inc. ($210.11) |
| 2020 | $20.92 | 1 | Relypsa, Inc. ($20.92) |
| 2018 | $14.63 | 1 | Roche Diagnostics Corporation ($14.63) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Rare Disease | ||||||
| 09/18/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: NEPHROLOGY | ||||||
| 08/27/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $26.60 | General |
| 08/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Nephrology | ||||||
| 08/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/20/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEPHROLOGY | ||||||
| 08/19/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Nephrology | ||||||
| 08/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $127.77 | General |
| 07/30/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.70 | General |
| 07/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Hyperkalemia | ||||||
| 07/16/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Nephrology | ||||||
| 07/15/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: NEPHROLOGY | ||||||
| 07/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $41.51 | General |
| 06/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $28.25 | General |
| 06/15/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,910 | 7,711 | $1.0M | $381,324 |
| 2022 | 25 | 3,282 | 6,821 | $924,062 | $331,960 |
| 2021 | 33 | 5,024 | 9,635 | $1.1M | $456,148 |
| 2020 | 37 | 5,474 | 10,968 | $1.1M | $447,802 |
Total Patients
17,690
Total Services
35,135
Medicare Billing
$1.6M
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 538 | 1,228 | $304,544 | $85,625 | 28.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 39 | 244 | $167,872 | $70,507 | 42.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 192 | 609 | $142,506 | $59,329 | 41.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 274 | 878 | $136,968 | $56,999 | 41.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 186 | 212 | $72,504 | $29,925 | 41.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 85 | 85 | $36,550 | $14,916 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 106 | $36,888 | $11,156 | 30.2% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 193 | 229 | $18,778 | $9,263 | 49.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 33 | $18,876 | $8,016 | 42.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 61 | $15,738 | $6,572 | 41.8% |
| 80069 | Kidney function blood test panel | Office | 2023 | 288 | 582 | $10,476 | $4,944 | 47.2% |
| 83735 | Magnesium level | Office | 2023 | 271 | 528 | $7,392 | $3,462 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 47 | $8,272 | $2,951 | 35.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 89 | 92 | $5,520 | $2,669 | 48.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 249 | 485 | $4,850 | $2,464 | 50.8% |
| 84100 | Phosphate level | Office | 2023 | 270 | 525 | $5,250 | $2,437 | 46.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 159 | 297 | $4,752 | $2,260 | 47.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 271 | 522 | $3,132 | $1,623 | 51.8% |
| 84156 | Total protein level, urine | Office | 2023 | 211 | 368 | $2,944 | $1,325 | 45.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 18 | $9,612 | $1,191 | 12.4% |
| 84550 | Uric acid level, blood | Office | 2023 | 124 | 235 | $2,350 | $1,041 | 44.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 77 | 123 | $1,476 | $696.18 | 47.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 32 | 53 | $1,378 | $695.36 | 50.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 24 | 28 | $784.00 | $374.08 | 47.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 31 | 35 | $560.00 | $290.15 | 51.8% |
About Dr. John Panos, MD
Dr. John Panos, MD is a Nephrology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407887128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Panos, MD has received a total of $4,533 in payments from pharmaceutical and medical device companies, with $1,335 received in 2024. These payments were reported across 198 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,419).
As a Medicare-enrolled provider, Panos has provided services to 17,690 Medicare beneficiaries, totaling 35,135 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Boca Raton, FL
- Active Since 07/05/2006
- Last Updated 06/18/2010
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1407887128
Products in Payments
- Kerendia (Drug) $854.76
- FARXIGA (Drug) $429.46
- KRYSTEXXA (Biological) $384.00
- RAYALDEE (Drug) $373.83
- Parsabiv (Drug) $324.47
- LOKELMA (Drug) $296.96
- JYNARQUE (Drug) $290.59
- Veltassa (Drug) $168.88
- BENLYSTA (Biological) $125.36
- TARPEYO (Drug) $121.07
- TAVNEOS (Drug) $107.18
- Aranesp (Biological) $98.05
- LUPKYNIS (Drug) $69.33
- ULTOMIRIS (Biological) $65.08
- ACTHAR (Biological) $50.91
- Ozempic (Drug) $47.26
- JARDIANCE (Drug) $45.73
- NEXLETOL (Drug) $24.32
- Ultomiris (Drug) $24.28
- ENTRESTO (Drug) $21.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Boca Raton
Marc Richards, Md, MD
Nephrology — Payments: $30,378
Nephrology $30,378
Jared Jaffe, Do, DO
Nephrology — Payments: $16,910
Nephrology $16,910
Craig Stemmer, Md, MD
Nephrology — Payments: $2,619
Nephrology $2,619
Dr. Rajesh Agarwala, M.d, M.D
Nephrology — Payments: $1,101
Nephrology $1,101
Dr. Mary Sifain, Do, DO
Nephrology — Payments: $854.11
Nephrology $854.11
Eric Lazar, Md, MD
Nephrology — Payments: $542.65
Nephrology $542.65